spacer
home > ebr > spring 2019 > jewel biomarkers can be found by digging in the right mine
PUBLICATIONS
European Biopharmaceutical Review

Jewel Biomarkers Can Be Found By Digging in the Right Mine

Biomarkers can be fantastic diagnostic tools, especially for rare diseases (1:2,000 up to about 1:100,000) for which an accurate identification may even be lifesaving if identified early on. Literature and experts see biomarkers as cornerstones for the development of new therapeutic approaches.

The EMA and FDA are proponents of seeing the therapeutic effects achieved through biomarker-based ‘theragnostic’. Historically, surrogate biomarkers were accepted in the past (for example, haemoglobin A1c for diabetes). Nowadays, however, biomarkers closely linked to a sickness and potential therapeutic intervention are even more welcome.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
Professor Hermann Mascher, Bioanalytical Consultant and founder of pharm-analyt Labor, has more than 100 publications in peer-reviewed journals (and more than 230 cumulative impact factor). He is the inventor of three patents for biomarkers in the area of rare LSDs (Gaucher, NP-C, and metachromatic leukodystrophy) which could be sold.
spacer
Professor Hermann Mascher
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Kallik’s Release 6 sets new benchmarks for speed, accuracy and efficiency

Tamworth, UK – 15 June 2019 – Global provider of labelling and artwork management solutions, Kallik, is launching an update to its AMS360 solution – its Release 6, transforming the experience of the business user, whilst defining new benchmarks for speed, accuracy, and efficiency of global labelling and artwork processes.
More info >>

White Papers

Investigator Portals: Facilitating and Streamlining Communication & Collaboration with Study Sites

ArisGlobal

ArisGlobal LLC Investigator site personnel are often frustrated with the lack of transparency and communication with their sponsors, leading to significant dissatisfaction and withdrawal from current and future studies. The adoption of investigator portals gives sponsors a platform that fosters collaboration and improves site management. Learn about five key areas of sponsor-investigator site interactions deserving of electronic communication and collaboration. Technology and design aspects are also covered.
More info >>

 
Industry Events

DIA 2019 Global Annual Meeting

23-27 June 2019, San Diego Convention Center

DIA 2019 is more than just a meeting: it’s where brilliant minds come together to create solutions. Thousands of global innovators will convene to engage in discussions on today’s hottest topics in the life sciences field, propose ways to combat daily challenges, and network to create lasting connections.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement